Cozymin Vapocaps Capsule
By Cozymin Vapocaps
Rx
10 Capsule in a Strip

Composition
Cetirizine(25mg) + Paracetamol(NA) + Phenylephrine(NA)

Manufacturer - Unimarck Healthcare Ltd
128, HPSIDC . Inds. Area , baddi -173205(H.P)

Expires on or after
April, 2027

liver
Limited data suggests that Cozymin Vapocaps Capsule is likely safe for individuals with liver disease. It appears that adjusting the dosage of Cozymin Vapocaps Capsule may not be necessary for these patients. It is recommended to seek advice from your doctor before using this product to ensure its appropriateness for your specific situation.

kidney
Cozymin Vapocaps Capsule should be used carefully in individuals with kidney disease. Dosage adjustment may be necessary and consultation with a healthcare provider is advised. Avoid using in serious kidney conditions; it may induce drowsiness in individuals with end-stage kidney disease.

alcohol
Consuming alcohol with Cozymin Vapocaps Capsule is not safe. It's important to avoid alcohol while taking this medication.

driving
Cozymin Vapocaps Capsule typically does not impact your driving ability.

pregnancy
During pregnancy, using Cozymin Vapocaps Capsule may not be safe. Animal studies have indicated potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before considering its use.

breastfeeding
Cozymin Vapocaps Capsule is considered safe to use while breastfeeding, based on limited human data showing no significant risks to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹35.1
₹39
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025